MS drug Lemtrada investigators protest FDA decision

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

MS drug Lemtrada investigators protest FDA decision

Postby MSUK » Fri Jan 17, 2014 2:00 am

Several multiple sclerosis (MS) experts who were involved in the clinical development program for alemtuzumab (Lemtrada, Genzyme) have voiced their disappointment and frustration over the recent decision by the US Food and Drug Administration (FDA) not to approve the drug.

Stephen Krieger, MD, from Mount Sinai Medical Center, New York; Edward Fox, MD, from the Multiple Sclerosis Clinic of Central Texas, Round Rock; and Jeffrey Cohen, MD, from Cleveland Clinic, Ohio, all told Medscape Medical News that they strongly disagree with the FDA decision and are worried about the consequences, which could include patients sourcing the drug from other countries but not being monitored for the serious safety issues.... Read More -
User avatar
Family Elder
Posts: 2501
Joined: Wed Oct 14, 2009 2:00 pm


Re: MS drug Lemtrada investigators protest FDA decision

Postby ChrisDeMuthJr » Fri Jan 17, 2014 6:06 am

The FDA Nixes a Pathbreaking Drug for MS: ... #printMode
Posts: 2
Joined: Fri Jan 17, 2014 5:41 am

Return to Campath (Lemtrada, Alemtuzumab)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service